agmatine has been researched along with Acute Confusional Senile Dementia in 7 studies
Agmatine: Decarboxylated arginine, isolated from several plant and animal sources, e.g., pollen, ergot, herring sperm, octopus muscle.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Agmatine was administered intraperitoneally at the doses of 10, 20, 30, 40 and 80 mg/kg/daily to adult male NMRI mice for 10 days after which the behavioral assessments were performed." | 5.72 | The effects of subchronic agmatine on passive avoidance memory, anxiety-like behavior and hippocampal Akt/GSK-3β in mice. ( Amiri, Z; Esmaili, Z; Moezi, L; Moosavi, M; Ostovan, VR; Pirsalami, F, 2022) |
| "Agmatine was administered intraperitoneally at the doses of 10, 20, 30, 40 and 80 mg/kg/daily to adult male NMRI mice for 10 days after which the behavioral assessments were performed." | 1.72 | The effects of subchronic agmatine on passive avoidance memory, anxiety-like behavior and hippocampal Akt/GSK-3β in mice. ( Amiri, Z; Esmaili, Z; Moezi, L; Moosavi, M; Ostovan, VR; Pirsalami, F, 2022) |
| "Alzheimer's disease is an age related progressive neurodegenerative disorder characterized by decline in cognitive functions, such as memory loss and behavioural abnormalities." | 1.62 | Evidences for agmatine alterations in Aβ ( Dixit, MP; Kotagale, NR; Rahmatkar, SN; Raut, P; Taksande, BG; Umekar, MJ, 2021) |
| "Depression is one of the most common psychiatric symptoms in Alzheimer's disease (AD), and several studies have shown that oxidative stress plays a key role in the etiopathology of both AD and depression." | 1.48 | Agmatine attenuates depressive-like behavior and hippocampal oxidative stress following amyloid β (Aβ1-40) administration in mice. ( de Souza, V; Farina, M; Gonçalves, CL; Guerra de Souza, AC; Hartwig, JM; Prediger, RD, 2018) |
| "The risk of Alzheimer's disease (AD) is higher in patients with type 2 diabetes mellitus (T2DM)." | 1.46 | Agmatine ameliorates type 2 diabetes induced-Alzheimer's disease-like alterations in high-fat diet-fed mice via reactivation of blunted insulin signalling. ( Jung, H; Kang, S; Kim, CH; Kim, E; Lee, JE; Song, HT, 2017) |
| "Agmatine (Agm) has been shown to exert neuroprotective effects in central nervous system disorders." | 1.40 | Agmatine improves cognitive dysfunction and prevents cell death in a streptozotocin-induced Alzheimer rat model. ( Bokara, KK; Cho, HJ; Hur, BE; Lee, JE; Lee, KM; Lee, WT; Park, KA; Song, J; Yang, W, 2014) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (57.14) | 24.3611 |
| 2020's | 3 (42.86) | 2.80 |
| Authors | Studies |
|---|---|
| Ostovan, VR | 1 |
| Amiri, Z | 1 |
| Moezi, L | 1 |
| Pirsalami, F | 1 |
| Esmaili, Z | 1 |
| Moosavi, M | 2 |
| Kotagale, N | 1 |
| Deshmukh, R | 1 |
| Dixit, M | 1 |
| Fating, R | 1 |
| Umekar, M | 1 |
| Taksande, B | 1 |
| Dixit, MP | 1 |
| Rahmatkar, SN | 1 |
| Raut, P | 1 |
| Umekar, MJ | 1 |
| Taksande, BG | 1 |
| Kotagale, NR | 1 |
| Guerra de Souza, AC | 1 |
| Gonçalves, CL | 1 |
| de Souza, V | 1 |
| Hartwig, JM | 1 |
| Farina, M | 1 |
| Prediger, RD | 1 |
| Hooshmandi, E | 1 |
| Ghasemi, R | 1 |
| Iloun, P | 1 |
| Song, J | 1 |
| Hur, BE | 1 |
| Bokara, KK | 1 |
| Yang, W | 1 |
| Cho, HJ | 1 |
| Park, KA | 1 |
| Lee, WT | 1 |
| Lee, KM | 1 |
| Lee, JE | 2 |
| Kang, S | 1 |
| Kim, CH | 1 |
| Jung, H | 1 |
| Kim, E | 1 |
| Song, HT | 1 |
7 other studies available for agmatine and Acute Confusional Senile Dementia
| Article | Year |
|---|---|
The effects of subchronic agmatine on passive avoidance memory, anxiety-like behavior and hippocampal Akt/GSK-3β in mice.
Topics: Agmatine; Alzheimer Disease; Animals; Anxiety; Avoidance Learning; Behavior, Animal; Biological Fact | 2022 |
Agmatine ameliorates manifestation of depression-like behavior and hippocampal neuroinflammation in mouse model of Alzheimer's disease.
Topics: Agmatine; Alzheimer Disease; Amyloid beta-Peptides; Animals; Depression; Disease Models, Animal; Hip | 2020 |
Evidences for agmatine alterations in Aβ
Topics: Agmatine; Alzheimer Disease; Amyloid beta-Peptides; Animals; Carboxy-Lyases; Cognition Disorders; Hi | 2021 |
Agmatine attenuates depressive-like behavior and hippocampal oxidative stress following amyloid β (Aβ1-40) administration in mice.
Topics: Agmatine; Alzheimer Disease; Amyloid beta-Peptides; Animals; Antidepressive Agents; Antioxidants; De | 2018 |
The neuroprotective effect of agmatine against amyloid β-induced apoptosis in primary cultured hippocampal cells involving ERK, Akt/GSK-3β, and TNF-α.
Topics: Agmatine; Alzheimer Disease; Amyloid beta-Peptides; Animals; Apoptosis; Cell Survival; Extracellular | 2019 |
Agmatine improves cognitive dysfunction and prevents cell death in a streptozotocin-induced Alzheimer rat model.
Topics: Agmatine; Alzheimer Disease; Animals; Cognition Disorders; Disease Models, Animal; Male; Rats; Strep | 2014 |
Agmatine ameliorates type 2 diabetes induced-Alzheimer's disease-like alterations in high-fat diet-fed mice via reactivation of blunted insulin signalling.
Topics: Agmatine; Alzheimer Disease; Animals; Blood Glucose; Brain; Diabetes Mellitus, Type 2; Diet, High-Fa | 2017 |